RT Journal Article
T1 Executive summary on the treatment of type 2 diabetes mellitus in elderly or frail individuals. 2022 update of the 2018 consensus document "Treatment of type 2 diabetes mellitus in the elderly".
A1 Gomez-Peralta, F
A1 Carrasco-Sanchez, F J
A1 Perez, A
A1 Escalada, J
A1 Alvarez-Guisasola, F
A1 Miranda-Fernandez-Santos, C
A1 Mediavilla-Bravo, J J
A1 Gomez-Huelgas, Ricardo
K1 Antidiabetic treatment
K1 Diabetes mellitus tipo 2
K1 Edad avanzada
K1 Elderly
K1 Fragilidad
K1 Frailty
K1 Technology applied to diabetes
K1 Tecnología aplicada a la diabetes
K1 Tratamiento antidiabético
K1 Type 2 diabetes mellitus
AB The population with type 2 DM (DM2) is highly heterogeneous, representing an important challenge for healthcare professionals. The therapeutic choice should be individualized, considering the functional status, frailty, the occurrence of comorbidities, and the preferences of patients and their caregivers. New evidence on the cardiovascular and renal protection of specific therapeutic groups and on the usefulness of new technologies for DM2 management, among other aspects, warrant an update of the consensus document on the DM2 in the elderly that was published in 2018.
PB Elsevier
YR 2022
FD 2022-10-01
LK http://hdl.handle.net/10668/22489
UL http://hdl.handle.net/10668/22489
LA en
NO Gómez-Peralta F, Carrasco-Sánchez FJ, Pérez A, Escalada J, Álvarez-Guisasola F, Miranda-Fernández-Santos C, et al. Executive summary on the treatment of type 2 diabetes mellitus in elderly or frail individuals. 2022 update of the 2018 consensus document "Treatment of type 2 diabetes mellitus in the elderly". Rev Clin Esp (Barc). 2022 Oct;222(8):496-499
DS RISalud
RD Apr 5, 2025